摘要
目的观察强心康颗粒联合耳穴疗法应用于慢性心力衰竭(以下简称“慢性心衰”)新型冠状病毒(以下简称“新冠”)感染患者的效果。方法选取72例慢性心衰新冠感染患者,随机分为观察组与对照组,各36例。对照组给予利尿剂、血管紧张素转换酶抑制剂(ACEI)、β受体阻滞剂治疗,观察组在对照组基础上给予强心康颗粒联合耳穴疗法,两组疗程均为4周,观察两组中医证候积分、6 min步行试验、广泛性焦虑量表(GAD-7)积分、睡眠时间及N末端脑钠肽前体(NT-proBNP)水平。结果治疗后,两组患者中医证候积分、6 min步行试验、GAD-7积分、睡眠时间、NT-proBNP等指标均较治疗前明显改善,且观察组改善情况均优于对照组,差异均有统计学意义(P<0.05)。结论强心康颗粒联合耳穴疗法应用于慢性心衰新冠感染患者疗效显著。
Objective To observe the curative effect of Qiangxinkang granule combined with auricular point therapy on patients with chronic heart failure after COVID-19.Methods A total of 72 cases with chronic heart failure after COVID-19 were selected and randomly divided into an observation group and a control group,with 36 cases in each.The control group was treated with diuretics,ACEI,and receptor blockers,while the observation group was treated with diuretics,ACEI,receptor blockers,Qiangxinkang granules,and auricular point therapy.After 4 weeks of treatment,TCM syndrome score,6-min walking test,General Anxiety Scale(GAD-7)score,sleep time and NT-proBNP level of the two groups were observed.Results After treatment,TCM syndrome score,6-min walking test,GAD-7 score,sleep time,NT-proBNP and other indicators of patients in both groups were significantly improved compared with those before treatment,and the improvement in the observation group was better than that in the control group,and the difference was statistical significance(P<0.05).Conclusion Qiangxinkang granule combined with auricular point therapy has a significant effect on patients with chronic heart failure after COVID-19.
作者
周淑平
ZHOU Shuping(Department of Cardiology,The First Clinical Hospital,Jilin College of Traditional Chinese Medicine,Jilin Province,Changchun 130021,China)
出处
《中国中医药现代远程教育》
2025年第5期130-133,共4页
Chinese Medicine Modern Distance Education of China
基金
吉林省卫生健康科技能力提升项目【No.2021LC044】。
关键词
慢性心力衰竭
新型冠状病毒感染
强心康颗粒
耳穴疗法
中医综合疗法
chronic heart failure
COVID-19
Qiangxinkang granule
auricular point therapy
comprehensive therapy of traditional Chinese medicine
